Trial Profile
Parallel Group Trial to Evaluate the Pharmacokinetics and Safety / Tolerability of Single-Dose Treatment With Rotigotine Continuous Delivery System (10 cm2 / 4.5 mg) in Japanese and Caucasian Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Rotigotine (Primary)
- Indications Fibromyalgia; Parkinson's disease; Restless legs syndrome
- Focus Pharmacokinetics
- Sponsors UCB
- 15 Apr 2015 New trial record